These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 6970304

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins.
    Chenoweth DE, Cooper SW, Hugli TE, Stewart RW, Blackstone EH, Kirklin JW.
    N Engl J Med; 1981 Feb 26; 304(9):497-503. PubMed ID: 7453783
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Use of cardiopulmonary bypass decreases leukocyte count and activation of the complement system].
    Bochenek A, Religa Z, Kokot F, Knapik P, Wnuk R, Komarski K, Wojnar J, Pietrzycki A, Skiba J.
    Kardiol Pol; 1992 Feb 26; 36(2):67-72. PubMed ID: 1583828
    [Abstract] [Full Text] [Related]

  • 5. The effects of methylprednisolone on complement-mediated neutrophil activation during cardiopulmonary bypass.
    Tennenberg SD, Bailey WW, Cotta LA, Brodt JK, Solomkin JS.
    Surgery; 1986 Aug 26; 100(2):134-42. PubMed ID: 3738745
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Impact of pexelizumab, an anti-C5 complement antibody, on total mortality and adverse cardiovascular outcomes in cardiac surgical patients undergoing cardiopulmonary bypass.
    Shernan SK, Fitch JC, Nussmeier NA, Chen JC, Rollins SA, Mojcik CF, Malloy KJ, Todaro TG, Filloon T, Boyce SW, Gangahar DM, Goldberg M, Saidman LJ, Mangano DT, Pexelizumab Study Investigators.
    Ann Thorac Surg; 2004 Mar 26; 77(3):942-9; discussion 949-50. PubMed ID: 14992903
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Complement as a mediator of granulocyte adherence and margination: studies based on the acute neutropenia of filtration leukapheresis.
    Fehr J.
    Prog Clin Biol Res; 1977 Mar 26; 13():243-58. PubMed ID: 400757
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Neutropenia induced by systemic infusion of chemotactic factors.
    O'Flaherty JT, Showell HJ, Ward PA.
    J Immunol; 1977 May 26; 118(5):1586-9. PubMed ID: 858915
    [Abstract] [Full Text] [Related]

  • 17. Increased expression of an adhesion-promoting surface glycoprotein in the granulocytopenia of hemodialysis.
    Arnaout MA, Hakim RM, Todd RF, Dana N, Colten HR.
    N Engl J Med; 1985 Feb 21; 312(8):457-62. PubMed ID: 3881672
    [Abstract] [Full Text] [Related]

  • 18. Neutrophil dysfunction in sepsis. II. Evidence for the role of complement activation products in cellular deactivation.
    Solomkin JS, Jenkins MK, Nelson RD, Chenoweth D, Simmons RL.
    Surgery; 1981 Aug 21; 90(2):319-27. PubMed ID: 7256544
    [Abstract] [Full Text] [Related]

  • 19. Effects of cardiopulmonary bypass on pulmonary leukostasis and complement activation.
    Howard RJ, Crain C, Franzini DA, Hood CI, Hugli TE.
    Arch Surg; 1988 Dec 21; 123(12):1496-501. PubMed ID: 3190431
    [Abstract] [Full Text] [Related]

  • 20. Cardiopulmonary bypass primes polymorphonuclear leukocytes.
    Schwartz JD, Shamamian P, Schwartz DS, Grossi EA, Jacobs CE, Steiner F, Minneci PC, Baumann FG, Colvin SB, Galloway AC.
    J Surg Res; 1998 Mar 21; 75(2):177-82. PubMed ID: 9655092
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.